Statistik Asas
| LEI | 54930037L0NBIPZ5S663 |
| CIK | 1141103 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cross Country Healthcare, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or other jurisdiction of incorporation) (Com |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| August 6, 2025 |
CROSS COUNTRY HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS BOCA RATON, Fla., August 6, 2025-Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information: Variance Variance Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2 |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| May 7, 2025 |
CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS BOCA RATON, Fla., May 7, 2025-Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 7, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| April 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-33169 Cross Co |
|
| March 5, 2025 |
List of subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Subsidiary Place of Incorporation Assignment America, LLC Delaware Cejka Search, LLC Delaware Credent Verification and Licensing Services, LLC Delaware Cross Country DAS, Inc. Delaware Cross Country Holdco (Cyprus) Limited Cyprus Cross Country Infotech, Pvt. Ltd. India Cross Country Staffing, Inc. Delaware Cross Country Tech, LLC Delaware Intellify Talent Solution |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 5, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-33169 Cross Country Healthcare, In |
|
| March 5, 2025 |
Exhibit 19.1 This memorandum sets forth the policies of Cross Country Healthcare, Inc. (the "Company") concerning restrictions on purchasing or selling the Common Stock of the Company (the "Common Stock") while in possession of "inside" information and the disclosure of such information and restrictions on transactions in the Common Stock. All employees and non- employee directors of the Company a |
|
| March 5, 2025 |
CROSS COUNTRY HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS BOCA RATON, Fla., March 5, 2025-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs |
|
| February 28, 2025 |
Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction Exhibit 99.1 Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction BOCA RATON, Fla. – February 28, 2025 – Cross Country Healthcare, Inc. (“Cross Country” or the “Company”) (NASDAQ: CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya He |
|
| February 28, 2025 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or other jurisdiction of incorporation) (Com |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2025 Cross Country Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2025 Cross Country Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 22, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2)) ☒ D |
|
| January 6, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2)) ☐ D |
|
| January 6, 2025 |
CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) Cross Country Healthcare, Inc. |
|
| January 6, 2025 |
EXHIBIT 99.2 LIMITED POWER OF ATTORNEY Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or |
|
| January 6, 2025 |
Exhibit 99.3 SCHEDULE A Funds Date Number of Shares Bought Price Per Share($) (1)(2) 12/19/2024 50,720 17.92479 (3) 12/20/2024 135,700 17.90460 12/23/2024 34,522 17.88283 (4) 12/24/2024 15,526 17.94974 (5) 12/26/2024 18,581 17.96386 (6) 12/27/2024 27,614 17.98054 (7) 12/30/2024 38,635 18.00899 (8) 12/31/2024 12,681 18.11968 (9) 1/2/2025 43,316 18.11946 (10) TB(1) Excludes commissions and other exe |
|
| December 20, 2024 |
EXHIBIT 99.3 LIMITED POWER OF ATTORNEY Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or |
|
| December 20, 2024 |
EXHIBIT 99.2 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the Shares of Cross Country Healthcare, Inc. dated as of December 20, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the previsions of Rule13d-1(k) |
|
| December 20, 2024 |
EXHIBIT 99.1 SCHEDULE A Funds Date Number of Shares Bought Price Per Share($) (1)(2) 10/18/2024 2,410 12.917504(3) 10/21/2024 3,297 12.138269(4) 10/22/2024 1,932 11.861352(5) 10/25/2024 30 11.502906(6) 11/12/2024 3,422 10.620428(7) 11/13/2024 4,095 10.252791(8) 11/14/2024 429 9.642175(9) 12/2/2024 2,358 11.185089(10) 12/3/2024 316 11.208425(11) 12/4/2024 652,042 18.096773 (12) 12/5/2024 387,450 18 |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 Cross Country Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| December 4, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash · Cross Country stockholders to receive $18.61 per share · Expands Aya’s client service and delivery capabilities with Cross Country’s nearly 40-year history of clinical excellence and quality patient care · Provides clinicians with greater flexibility and convenience by tap |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
The following material was posted to the Cross Country Healthcare, Inc. (“Cross Country”) intranet page on December 4, 2024 in connection with the proposed acquisition of Cross Country by Aya Healthcare, Inc. Exciting News: Cross Country’s Next Chapter We’re thrilled to announce that Cross Country has agreed to be acquired by Aya Healthcare. This is an incredible milestone in our nearly 40-year hi |
|
| December 4, 2024 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of December 3, 2024 among CROSS COUNTRY HEALTHCARE, INC., AYA HOLDINGS II INC., SPARK MERGER SUB ONE INC. and solely for purposes of Section 11.14, AYA HEALTHCARE, INC. TABLE OF CONTENTS Page Article 1 Definitions Section 1.01. Definitions 1 Section 1.02. Other Definitional and Interpretative Provisions 11 Article 2 The Merger Section 2.01. The Mer |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 Cross Country Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 4, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash · Cross Country stockholders to receive $18.61 per share · Expands Aya’s client service and delivery capabilities with Cross Country’s nearly 40-year history of clinical excellence and quality patient care · Provides clinicians with greater flexibility and convenience by tap |
|
| December 4, 2024 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of December 3, 2024 among CROSS COUNTRY HEALTHCARE, INC., AYA HOLDINGS II INC., SPARK MERGER SUB ONE INC. and solely for purposes of Section 11.14, AYA HEALTHCARE, INC. TABLE OF CONTENTS Page Article 1 Definitions Section 1.01. Definitions 1 Section 1.02. Other Definitional and Interpretative Provisions 11 Article 2 The Merger Section 2.01. The Mer |
|
| November 13, 2024 |
SC 13G/A 1 ccrna1.htm PRINCIPAL GLOBAL INVESTORS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CROSS COUNTRY HEALTHCARE INC (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 227483104 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of th |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| November 6, 2024 |
CROSS COUNTRY HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS BOCA RATON, Fla., November 6, 2024-Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q3 2024 vs Q3 2024 vs Dollars are in thousands, except per share amounts Q3 2024 Q3 2023 |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 24, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 24, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 24, 2024 |
CROSS COUNTRY HEALTHCARE TO ATTEND UBS GLOBAL HEALTHCARE CONFERENCE Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND UBS GLOBAL HEALTHCARE CONFERENCE BOCA RATON, Fla.—October 24, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the UBS Global Healthcare Conference taking place November 11-14, 2024 at the Terranea Resort Hotel in Rancho Palos Verdes, CA. John Martins, President & Chief Executiv |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 18, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 18, 2024 |
Exhibit 99.1 Cross Country Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Wednesday, November 6, 2024 BOCA RATON, Fla.—October 18, 2024—Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) in |
|
| August 21, 2024 |
Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE AND THE 17TH ANNUAL BARRINGTON RESEARCH VIRTUAL FALL INVESTMENT CONFERENCE BOCA RATON, Fla.—August 21, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: •The Morgan Stanley 22nd Annual Global He |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 21, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| July 31, 2024 |
CROSS COUNTRY HEALTHCARE ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS BOCA RATON, Fla., July 31, 2024-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 29, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| July 29, 2024 |
Exhibit 10.1 AMENDMENT NO. 7 TO ABL CREDIT AGREEMENT AMENDMENT NO. 7 TO ABL CREDIT AGREEMENT, dated as of July 29, 2024 (this “Amendment No. 7”), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in such capacit |
|
| July 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 11, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| July 11, 2024 |
Exhibit 99.1 Cross Country Healthcare to Hold Second Quarter 2024 Earnings Conference Call on Wednesday, July 31, 2024 BOCA RATON, Fla.—July 11, 2024—Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends t |
|
| May 23, 2024 |
CROSS COUNTRY HEALTHCARE TO ATTEND CITIZENS JMP MEDICAL DEVICES AND HEALTHCARE SERVICES FORUM Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND CITIZENS JMP MEDICAL DEVICES AND HEALTHCARE SERVICES FORUM BOCA RATON, Fla.—May 23, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Citizens JMP Medical Devices and Healthcare Services Forum taking place June 20, 2024 at the Boston Harbor Hotel. John Martins, President & Ch |
|
| May 23, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 23, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 22, 2024 |
As filed with the Securities and Exchange Commission on May 22, 2024 As filed with the Securities and Exchange Commission on May 22, 2024 Registration No. |
|
| May 22, 2024 |
Cross Country Healthcare, Inc. 2024 Omnibus Incentive Plan. Exhibit 99.1 CROSS COUNTRY HEALTHCARE, INC. 2024 OMNIBUS INCENTIVE PLAN Section 1. Effectiveness and Purpose. Effective as of the Effective Date, the Cross Country Healthcare, Inc. 2024 Omnibus Incentive Plan (as may be amended from time to time, the “Plan”) is hereby established. The purpose of the Plan is to provide employees of Cross Country Healthcare, Inc., a Delaware corporation (together wi |
|
| May 22, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Cross Country Healthcare, Inc. |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 15, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 13, 2024 |
Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND THE WILLIAM BLAIR 44TH ANNUAL GROWTH STOCK CONFERENCE AND THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE BOCA RATON, Fla.—May 13, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: •The William Blair 44th Annual Growth Stock Conference taking place June 4-6, |
|
| May 13, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 9, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 3, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 3, 2024 |
CROSS COUNTRY HEALTHCARE TO ATTEND BENCHMARK’S HEALTHCARE HOUSE CALL INVESTOR CONFERENCE Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND BENCHMARK’S HEALTHCARE HOUSE CALL INVESTOR CONFERENCE BOCA RATON, Fla.—May 3, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in Benchmark’s Healthcare House Call Virtual One-on-One Investor Conference taking place May 21-22, 2024. William J. Burns, Executive Vice President & Chie |
|
| May 2, 2024 |
Exhibit 10.2 Addendum to the Confidential Separation Agreement and General Release of All Claims Between Cross Country Staffing, Inc. d/b/a Cross Country Healthcare Services And Dan White This Addendum (“Addendum”) is made to Confidential Separation Agreement and General Release of All Claims (“Separation Agreement”) entered into between Dan White (“Employee”) and Cross Country Staffing, Inc. d/b/ |
|
| May 2, 2024 |
Amended and Restated By-laws of the Registrant Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CROSS COUNTRY HEALTHCARE, INC. 1.MEETINGS OF STOCKHOLDERS. 1.1Annual Meeting. The annual meeting of stockholders of the Corporation shall be held at such date, place and time as determined by the Board of Directors (the “Board”). 1.2Place and Time of Meetings. Meetings of the stockholders may be held in or outside Delaware at the place and time specified |
|
| May 2, 2024 |
Exhibit 10.1 CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS February 14, 2024 Dan White 402 Seville Avenue Newport Beach, California 92661 Re: Confidential Separation Agreement and General Release of All Claims Dear Dan: This letter confirms that on February 14, 2024, I delivered to you the enclosed Confidential Separation Agreement and General Release of All Claims (“Separati |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 1, 2024 |
CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS BOCA RATON, Fla., May 1, 2024-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 202 |
|
| April 10, 2024 |
Exhibit 99.1 Cross Country Healthcare to Hold First Quarter 2024 Earnings Conference Call on Wednesday, May 1, 2024 BOCA RATON, Fla.—April 10, 2024—Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2024 financial results on Wednesday, May 1, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends to dis |
|
| April 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 10, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☑ Filed by a Party other than the Registrant ❑ Check the appropriate box: ❑ Preliminary Proxy Statement ❑ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Defi |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 1, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| February 23, 2024 |
CROSS COUNTRY HEALTHCARE TO ATTEND THE OPPENHEIMER 34TH ANNUAL HEALTHCARE CONFERENCE Exhibit 99.1 CROSS COUNTRY HEALTHCARE TO ATTEND THE OPPENHEIMER 34TH ANNUAL HEALTHCARE CONFERENCE BOCA RATON, Fla.—February 23, 2024—Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Oppenheimer 34th Annual Healthcare Med-Tech & Services Conference taking place March 12-13, 2024. William J. Burns, Executive Vice President & Chi |
|
| February 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-33169 Cross Country Healthcare, In |
|
| February 23, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 23, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| February 23, 2024 |
List of subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Subsidiary Place of Incorporation Assignment America, LLC Delaware Cejka Search, LLC Delaware Credent Verification and Licensing Services, LLC Delaware Cross Country DAS, Inc. Delaware Cross Country Holdco (Cyprus) Limited Cyprus Cross Country Infotech, Pvt. Ltd. India Cross Country Staffing, Inc. Delaware Cross Country Tech, LLC Delaware Intellify Talent Solution |
|
| February 23, 2024 |
Compensation Recoupment (Clawback) Policy Exhibit 97.1 CROSS COUNTRY HEALTHCARE, INC. COMPENSATION RECOUPMENT POLICY Effective as of December 1, 2023 I.Introduction The Board of Directors (the “Board”) of Cross Country Healthcare, Inc. (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s |
|
| February 21, 2024 |
CROSS COUNTRY HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS Exhibit 99.1 CROSS COUNTRY HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS BOCA RATON, Fla., February 21, 2024-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2023. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2023 Variance Q4 202 |
|
| February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 21, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 14, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| February 13, 2024 |
CCRN / Cross Country Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0706-crosscountryhealthcar.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Cross Country Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 227483104 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate b |
|
| February 9, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Cross Country Healthcare Inc (Name of Issuer) Common Stock (Title of Class of Securities) 227483104 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 1, 2024 |
Exhibit 99.1 Cross Country Healthcare to Hold Fourth Quarter and Full Year 2023 Earnings Conference Call on Wednesday, February 21, 2024 BOCA RATON, Fla.—February 1, 2024—Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2023 financial results on Wednesday, February 21, 2024 at 5:00 p.m. Eastern Time. Cross Country Hea |
|
| February 1, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| November 1, 2023 |
Cross Country Healthcare Announces Third Quarter 2023 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Third Quarter 2023 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-November 1, 2023-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2023. SELECTED FINANCIAL INFORMATION: Variance Variance Q3 2023 vs Q3 2023 vs Dollars are in thousands, except per share amount |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| October 10, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| October 10, 2023 |
Exhibit 99.1 Cross Country Healthcare to Hold Third Quarter 2023 Earnings Conference Call on Wednesday, November 1, 2023 BOCA RATON, Fla.-(BUSINESS WIRE)-October 10, 2023-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its third quarter 2023 financial results on Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (t |
|
| October 2, 2023 |
Exhibit 10.1 [Execution] AMENDMENT NO. 6 TO ABL CREDIT AGREEMENT AMENDMENT NO. 6 TO ABL CREDIT AGREEMENT, dated as of September 29, 2023 (this “Amendment No. 6”), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assign |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Co |
|
| August 14, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| August 14, 2023 |
Exhibit 99.1 Cross Country Healthcare to Attend the 16th Annual Barrington Research Virtual Fall Investment Conference BOCA RATON, Fla.-(BUSINESS WIRE)-August 14, 2023-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the 16th Annual Barrington Research Virtual Fall Investment Conference taking place on September 14, 2023. William |
|
| August 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 2, 2023 |
Cross Country Healthcare Announces Second Quarter 2023 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Second Quarter 2023 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-August 2, 2023-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2023. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2023 vs Q2 2023 vs Dollars are in thousands, except per share amounts Q2 |
|
| July 11, 2023 |
Exhibit 99.1 Cross Country Healthcare to Hold Second Quarter 2023 Earnings Conference Call on Wednesday, August 2, 2023 BOCA RATON, Fla.-(BUSINESS WIRE)-July 11, 2023-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its second quarter 2023 financial results on Wednesday, August 2, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “C |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| May 22, 2023 |
Cross Country Healthcare to Attend the Jefferies 2023 Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the Jefferies 2023 Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-May 22, 2023-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Jefferies 2023 Healthcare Conference taking place June 7-9, 2023 at the Marriott Marquis in New York City. On Thursday, June 8, John Martins, Pr |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 3, 2023 |
Cross Country Healthcare Announces First Quarter 2023 Financial Results Exhibit 99.1 Cross Country Healthcare Announces First Quarter 2023 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-May 3, 2023-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2023. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2023 vs Q1 2023 vs Dollars are in thousands, except per share amounts Q1 2023 |
|
| April 28, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| April 28, 2023 |
Cross Country Healthcare to Attend the Benchmark Healthcare House Call Virtual Conference Exhibit 99.1 Cross Country Healthcare to Attend the Benchmark Healthcare House Call Virtual Conference BOCA RATON, Fla.-(BUSINESS WIRE)-April 28, 2023-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Benchmark Healthcare House Call Virtual Conference taking place on May 23, 2023. John Martins, President & Chief Executive Offic |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| April 18, 2023 |
Exhibit 10.1 Execution Version SECOND AMENDMENT TO TERM LOAN CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of April 14, 2023 (this “Amendment”), is entered into by and among the Lenders (as defined below) party hereto, WILMINGTON TRUST, NATIONAL ASSOCIATION (“Wilmington Trust”) as administrative agent (in such capacity, “Administrative Agent”) and as collateral agent (in suc |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| April 17, 2023 |
Cross Country Healthcare to Attend the 2023 BofA Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the 2023 BofA Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-April 17, 2023-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the BofA Healthcare Conference taking place May 9–11, 2023 at the Encore Hotel in Las Vegas. John Martins, President & Chief Executive Officer, and Jos |
|
| April 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| April 10, 2023 |
Exhibit 99.1 Cross Country Healthcare to Hold First Quarter 2023 Earnings Conference Call on Wednesday, May 3, 2023 BOCA RATON, Fla.-(BUSINESS WIRE)-April 10, 2023-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2023 financial results on Wednesday, May 3, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company” |
|
| April 3, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| April 3, 2023 |
DEFA14A 1 ny20006364x2defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
| February 23, 2023 |
List of subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Subsidiary Place of Incorporation Assignment America, LLC Delaware Cejka Search, LLC Delaware Credent Verification and Licensing Services, LLC Delaware Cross Country DAS, Inc. Delaware Cross Country Holdco (Cyprus) Limited Cyprus Cross Country Infotech, Pvt. Ltd. India Cross Country Staffing, Inc. Delaware Cross Country Tech, LLC Delaware Medical Doctor Associates |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-33169 Cross Country Healthcare, In |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| February 22, 2023 |
Cross Country Healthcare Announces Fourth Quarter and Full Year 2022 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Fourth Quarter and Full Year 2022 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-February 22, 2023-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2022. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2022 |
|
| February 13, 2023 |
Exhibit 99.1 Cross Country Healthcare to Attend the Loop Capital Markets 2023 Investor Conference and the Oppenheimer 33rd Annual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-February 13, 2023-Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming virtual conferences: The Loop Capital Markets 2023 Investor Confere |
|
| February 13, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| February 9, 2023 |
CCRN / Cross Country Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Cross Country Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 227483104 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Cross Country Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 227483104 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| January 31, 2023 |
Exhibit 99.1 Cross Country Healthcare to Hold Fourth Quarter and Full Year 2022 Earnings Conference Call on Wednesday, February 22, 2023 BOCA RATON, Fla.-(BUSINESS WIRE)-January 31, 2023-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2022 financial results on Wednesday, February 22, 2023 at 5:00 p.m. Eastern Time. C |
|
| January 31, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| January 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2023 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| January 5, 2023 |
Cross Country Healthcare Announces New Appointment to Board of Directors Exhibit 99.1 Cross Country Healthcare Announces New Appointment to Board of Directors BOCA RATON, Fla.-(BUSINESS WIRE)-January 5, 2023-Cross Country Healthcare, Inc. (NASDAQ: CCRN) (the ?Company? or ?Cross Country?), a market-leading, tech-enabled workforce solutions platform and advisory firm, is pleased to announce that Dwayne L. Allen, 61, has been appointed to serve on the Company's Board of D |
|
| December 16, 2022 |
Amended and Restated By-laws of Cross Country Healthcare, Inc., effective as of December 12, 2022 Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CROSS COUNTRY HEALTHCARE, INC. 1. MEETINGS OF STOCKHOLDERS. 1.1 Annual Meeting. The annual meeting of stockholders of the Corporation shall be held at such date, place and time as determined by the Board of Directors (the ?Board?). 1.2 Place and Time of Meetings. Meetings of the stockholders may be held in or outside Delaware at the place and time specif |
|
| December 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 22, 2022 |
Cross Country Healthcare Announces New Appointment to Board of Directors Exhibit 99.1 Cross Country Healthcare Announces New Appointment to Board of Directors BOCA RATON, Fla.-(BUSINESS WIRE)-November 21, 2022-Cross Country Healthcare, Inc. (NASDAQ: CCRN), a market-leading, tech-enabled workforce solutions platform and advisory firm, is pleased to announce that Venkat Bhamidipati, 56, has been elected to serve as a member of the Company's Board of Directors, November 1 |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 16, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| November 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| November 9, 2022 |
Cross Country Healthcare to Attend the 4th Annual Truist Securities Industrials and Services Summit Exhibit 99.1 false000114110300011411032022-11-092022-11-09 Cross Country Healthcare to Attend the 4th Annual Truist Securities Industrials and Services Summit BOCA RATON, Fla.-(BUSINESS WIRE)-November 9, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the 4th Annual Truist Securities Industrials and Services Summit taking pl |
|
| November 9, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 9, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ??????? FORM 10-Q ??????? ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ??????? CROSS COUNTRY HEALTHCARE, INC. |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 2, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 2, 2022 |
Cross Country Healthcare Announces Third Quarter 2022 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Third Quarter 2022 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-November 2, 2022-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2022. SELECTED FINANCIAL INFORMATION: Variance Variance Q3 2022 vs Q3 2022 vs Dollars are in thousands, except per share amount |
|
| October 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Cross Country Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 227483104 (CUSIP Number) JEFFR |
|
| October 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 13, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 13, 2022 |
Cross Country Healthcare to Attend the Credit Suisse 31st Annual Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the Credit Suisse 31st Annual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-October 13, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Credit Suisse 31st Annual Healthcare Conference taking place at the Terranea Resort in Rancho Palos Verdes, CA on November 7 - 10 |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 10, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 11, 2022 |
Exhibit 99.1 Cross Country Healthcare Announces Third Quarter 2022 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-October 10, 2022-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (t |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Co |
|
| September 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 14, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Com |
|
| September 14, 2022 |
Exhibit 99.1 Investor Day 2022 Cross Country Healthcare September 14, 2022 This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act, and are subject to the "safe harbor" created by those secti |
|
| September 1, 2022 |
JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0. |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Cross Country Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 227483104 (CUSIP Number) JEFFRE |
|
| August 17, 2022 |
Exhibit 99.1 Cross Country Healthcare to Host Investor Day on September 14, 2022, Highlighting Its Innovative Strategy BOCA RATON, Fla.-(BUSINESS WIRE)-August 17, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN), a market-leading tech-enabled workforce solutions platform and advisory firm, today announced that the organization will host its Investor Day event the morning of Wedne |
|
| August 17, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 17, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 16, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 16, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 16, 2022 |
Cross Country Healthcare Announces Authorization of a New $100 Million Stock Repurchase Program Exhibit 99.1 Cross Country Healthcare Announces Authorization of a New $100 Million Stock Repurchase Program BOCA RATON, Fla.-(BUSINESS WIRE)-August 16, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that the Company?s Board of Directors authorized the Company to repurchase up to $100 million of the Company?s shares of common stock under a new stock repurchase p |
|
| August 15, 2022 |
Cross Country Healthcare to Attend The 15th Annual Barrington Research Virtual Fall Conference Exhibit 99.1 Cross Country Healthcare to Attend The 15th Annual Barrington Research Virtual Fall Conference BOCA RATON, Fla.-(BUSINESS WIRE)-August 15, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the 15th Annual Barrington Research Virtual Fall Conference taking place on September 8, 2022. John Martins, President & Chief |
|
| August 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ——————— CROSS COUNTRY HEALTHCARE, INC. |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 3, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| August 3, 2022 |
Cross Country Healthcare Announces Second Quarter 2022 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Second Quarter 2022 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-August 3, 2022-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2022. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2022 vs Q2 2022 vs Dollars are in thousands, except per share amounts Q2 |
|
| July 11, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 11, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| July 11, 2022 |
Exhibit 99.1 Cross Country Healthcare Announces Second Quarter 2022 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-July 11, 2022-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the |
|
| May 18, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 13, 2022 |
Exhibit 99.1 Cross Country Healthcare to Attend the Benchmark 2022 Healthcare House Call Virtual Conference and the Jefferies 2022 Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-May 13, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Benchmark 2022 Healthcare House Call Virtual Conferenc |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ??????? FORM 10-Q ??????? ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ??????? CROSS COUNTRY HEALTHCARE, INC. |
|
| May 5, 2022 |
DocuSign Envelope ID: 5D460804-F0D8-45E9-B87E-4C4792986401 Exhibit 10.2 April 5, 2022 Daniel J. White 5815 Loma Verde Drive PO Box 1137 Rancho Santa Fe, CA 92067 Dear Dan, We are pleased to confirm our offer of employment to join Cross Country Healthcare Services, Inc. (the ?Company?) as Chief Commercial Officer (CCO). You will report to John Martins, Chief Executive Officer (CEO). Your start date |
|
| May 4, 2022 |
Cross Country Healthcare Announces First Quarter 2022 Financial Results Exhibit 99.1 Cross Country Healthcare Announces First Quarter 2022 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-May 4, 2022-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2022. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2022 vs Q1 2022 vs Dollars are in thousands, except per share amounts Q1 2022 |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 4, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 18, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 18, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 18, 2022 |
Cross Country Healthcare to Attend the 2022 BofA Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the 2022 BofA Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-April 18, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the BofA Healthcare Conference taking place May 10?12, 2022 at the Encore at the Wynn in Las Vegas. John Martins, President & Chief Executive Officer, |
|
| April 12, 2022 |
Exhibit 99.1 Cross Country Healthcare Announces First Quarter 2022 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-April 12, 2022-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the ?Com |
|
| April 12, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 12, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 5, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| April 7, 2022 |
Cross Country Healthcare Welcomes Daniel J. White to New Chief Commercial Officer Position Exhibit 99.1 Cross Country Healthcare Welcomes Daniel J. White to New Chief Commercial Officer Position BOCA RATON, Fla.-(BUSINESS WIRE)-April 7, 2022-Cross Country Healthcare, Inc., a market leading workforce solutions tech-enabled talent platform, staffing, recruitment, and advisory firm, today announced that Daniel J. White has joined the company as its first Chief Commercial Officer. A seasone |
|
| April 6, 2022 |
Cross Country Healthcare, Inc. 6551 Park of Commerce Boulevard, N.W. Boca Raton, Florida 33487 Correspondence Cross Country Healthcare, Inc. 6551 Park of Commerce Boulevard, N.W. Boca Raton, Florida 33487 April 6, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Janice Adeloye Jennifer Lop?z Molina Re: Cross Country Healthcare, Inc. Registration Statement on Form S-3 (File No. 333-263433) Ladies and Gentle |
|
| April 4, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? D |
|
| April 4, 2022 |
As filed with the Securities and Exchange Commission on April 4, 2022 As filed with the Securities and Exchange Commission on April 4, 2022 Registration No. |
|
| April 4, 2022 |
DEFA14A 1 ny20001668x2defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted |
|
| March 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 21, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| March 22, 2022 |
Exhibit 10.1 AMENDMENT NO. 5 TO ABL CREDIT AGREEMENT AND AMENDMENT NO. 2 TO GUARANTY AND SECURITY AGREEMENT AMENDMENT NO. 5 TO ABL CREDIT AGREEMENT AND AMENDMENT NO. 2 TO GUARANTY AND SECURITY AGREEMENT, dated as of March 21, 2022 (this ?Amendment No. 5?), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of the Lender G |
|
| March 10, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Cross Country Healthcare, Inc. |
|
| March 10, 2022 |
Power of attorney (included on the signature page of this registration statement) As filed with the Securities and Exchange Commission on March 10, 2022 Registration No. |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-33169 Cross Country Healthcare, In |
|
| February 28, 2022 |
Exhibit 14.1 CODE OF CONDUCT AND BUSINESS A.Purpose and Introduction It is the policy of Cross Country Healthcare, Inc. (the "Company" or "CCH") that all business, including that of its subsidiaries, is to be conducted in strict compliance with all applicable governmental laws, rules, and regulations, and in keeping with the highest level of business ethics. The Company expects honest and ethical |
|
| February 28, 2022 |
List of subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Subsidiary Place of Incorporation Assignment America, LLC Delaware Cejka Search, LLC Delaware Credent Verification and Licensing Services, LLC Delaware Cross Country Holdco (Cyprus) Limited Cyprus Cross Country Infotech, Pvt. Ltd. India Cross Country Tech, LLC Delaware Cross Country Staffing, Inc. Delaware Medical Doctor Associates, LLC Delaware New Mediscan II, L |
|
| February 23, 2022 |
Cross Country Healthcare Announces Fourth Quarter and Full Year 2021 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Fourth Quarter and Full Year 2021 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-February 23, 2022-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2021. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2021 |
|
| February 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 23, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| February 17, 2022 |
Cross Country Healthcare to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Present at Oppenheimer?s 32nd Annual Virtual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-February 17, 2022-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to present at the Oppenheimer 32nd Annual Virtual Healthcare Conference on Wednesday, March 16, 2022 at 2:00 p.m. Eastern Time. John Martins, |
|
| February 17, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 17, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| February 14, 2022 |
CCRN / Cross Country Healthcare, Inc. / Aristotle Capital Boston, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* CROSS COUNTRY HEALTHCARE INC. (Name of Issuer) Common Stock, Par Value of $0.0001 Per Share (Title of Class of Securities) 227483104 (CUSIP Number) Michel |
|
| February 9, 2022 |
CCRN / Cross Country Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Cross Country Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 227483104 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Cross Country Healthcare Inc (Name of Issuer) Common Stock (Title of Class of Securities) 227483104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Cross Country Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 227483104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| January 31, 2022 |
Exhibit 99.1 Cross Country Healthcare Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-January 31, 2022-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Wednesday, February 23, 2022 at 5:00 p.m. Eastern Time. Cr |
|
| January 31, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| January 19, 2022 |
Exhibit 10.2 EXECUTION COPY January 14, 2022 Mr. John A. Martins c/o Cross Country Healthcare, Inc. 6551 Park of Commerce Blvd., NW Boca Raton, Florida 33487 Dear Mr. Martins: Cross Country Healthcare, Inc., a Delaware corporation (the ?Company?), hereby agrees to continue to employ you, and you hereby agree to accept such continued employment, under the following terms and conditions: 1. Term of |
|
| January 19, 2022 |
Exhibit 99.1 Cross Country Healthcare Announces Co-Founder and CEO Kevin Clark to Transition to Chairman of the Board John A. Martins, the current Group President, Delivery promoted to President and CEO Company raises fourth quarter 2021 financial guidance BOCA RATON, Fla.-(BUSINESS WIRE)-January 19, 2022-Cross Country Healthcare, Inc., a market leading workforce solutions tech-enabled staffing, r |
|
| January 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2022 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| January 19, 2022 |
Exhibit 10.1 January 14, 2022 Mr. Kevin C. Clark c/o Cross Country Healthcare, Inc. 6551 Park of Congress Boulevard, N.W. Boca Raton, FL 33487 Dear Kevin: In connection with your transition from employment as the president and chief executive officer of Cross Country Healthcare, Inc. (the ?Company?) effective as of March 31, 2022 to non-executive chairman of the board of directors of the Company ( |
|
| December 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 16, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| November 19, 2021 |
Exhibit 10.2 AMENDMENT NO. 4 TO ABL CREDIT AGREEMENT AMENDMENT NO. 4 TO ABL CREDIT AGREEMENT, dated as of November 18, 2021 (this ?Amendment No. 4?), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in such cap |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 18, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Comm |
|
| November 19, 2021 |
Exhibit 10.1 FIRST INCREMENTAL AMENDMENT TO TERM LOAN CREDIT AGREEMENT This FIRST INCREMENTAL AMENDMENT TO CREDIT AGREEMENT, dated as of November 18, 2021 (this ?Amendment?), is entered into by and among the Lenders (as defined below), WILMINGTON TRUST, NATIONAL ASSOCIATION (?Wilmington Trust?) as administrative agent (in such capacity, ?Administrative Agent?) and as collateral agent (in such capa |
|
| November 12, 2021 |
Cross Country Healthcare to Attend the BofA Securities Virtual Home Care 2021 Conference Exhibit 99.1 Cross Country Healthcare to Attend the BofA Securities Virtual Home Care 2021 Conference BOCA RATON, Fla.-(BUSINESS WIRE)-November 12, 2021-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the BofA Securities Virtual Home Care 2021 Conference taking place December 6 - 7, 2021. Kevin C. Clark, Co-Founder & Chief Execut |
|
| November 12, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2021 CROSS COUNTRY HEALTHCARE INC (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ??????? FORM 10-Q ??????? ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ??????? CROSS COUNTRY HEALTHCARE, INC. |
|
| November 3, 2021 |
Cross Country Healthcare Announces Third Quarter 2021 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Third Quarter 2021 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-November 3, 2021-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2021. SELECTED FINANCIAL INFORMATION: Variance Variance Q3 2021 vs Q3 2021 vs Dollars are in thousands, except per share amount |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 3, 2021 CROSS COUNTRY HEALTHCARE INC (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| October 15, 2021 |
Cross Country Healthcare to Attend the Credit Suisse 30th Annual Virtual Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the Credit Suisse 30th Annual Virtual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-October 15, 2021-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Credit Suisse 30th Annual Virtual Healthcare Conference taking place November 8-11, 2021. William J. Burns, Executive Vic |
|
| October 15, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 15, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commi |
|
| October 7, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 7, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| October 7, 2021 |
EX-99.1 2 a52505782ex991.htm EXHIBIT 99.1 Exhibit 99.1 Cross Country Healthcare Announces Third Quarter 2021 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-October 7, 2021-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Wednesday, November 3, 2021 at 5:00 p.m. Easter |
|
| August 16, 2021 |
Exhibit 99.1 Cross Country Healthcare to Attend the 14th Annual Barrington Research Virtual Fall Investment Conference BOCA RATON, Fla.-(BUSINESS WIRE)-August 16, 2021-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the 14th Annual Barrington Research Virtual Fall Investment Conference taking place September 9, 2021. Kevin C. Cla |
|
| August 16, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 16, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ??????? FORM 10-Q ??????? ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ??????? CROSS COUNTRY HEALTHCARE, INC. |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| August 4, 2021 |
Cross Country Healthcare Announces Second Quarter 2021 Financial Results Exhibit 99.1 Cross Country Healthcare Announces Second Quarter 2021 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-August 4, 2021-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2021. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2021 vs Q2 2021 vs Dollars are in thousands, except per share amounts Q2 |
|
| July 30, 2021 |
Exhibit 99.1 Cross Country Healthcare Announces Change in Conference Call Details for Second Quarter 2021 Earnings BOCA RATON, Fla.-(BUSINESS WIRE)-July 30, 2021-Cross Country Healthcare, Inc. (Nasdaq: CCRN) is issuing the following updated dial-in numbers for its quarterly conference call to discuss its second quarter 2021 financial results on Wednesday, August 4, 2021 at 5:00 p.m. Eastern Time. |
|
| July 30, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 14, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commis |
|
| July 14, 2021 |
Exhibit 99.1 Cross Country Healthcare Announces Second Quarter 2021 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-July 14, 2021-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Wednesday, August 4, 2021 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the |
|
| July 14, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 14, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 8, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| June 14, 2021 |
Exhibit 10.1 Execution Version TERM LOAN CREDIT AGREEMENT by and among WILMINGTON TRUST, NATIONAL ASSOCIATION as Administrative Agent and Collateral Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, CROSS COUNTRY HEALTHCARE, INC. as Parent and Borrower, and THE SUBSIDIARIES OF PARENT IDENTIFIED HEREIN as Guarantors Dated as of June 8, 2021 Table of Contents Page 1. DEFINITIONS AND CONSTRU |
|
| June 14, 2021 |
Exhibit 10.2 [Execution] AMENDMENT NO. 3 TO ABL CREDIT AGREEMENT AMENDMENT NO. 3 TO ABL CREDIT AGREEMENT, dated as of June 8, 2021 (this ?Amendment No. 3?), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in s |
|
| June 14, 2021 |
Exhibit 2.1 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this ?Agreement?) is effective as of June 8, 2021, by and among (i) CROSS COUNTRY HEALTHCARE, INC., a Delaware corporation (the ?Buyer?), (ii) WORKFORCE SOLUTIONS GROUP, INCORPORATED, a California corporation (?WSG?), HEALTH TALENT STRATEGIES, INC., a California corporation (?HTS?), TALENT STRATEGIES, INC., a California corporatio |
|
| June 9, 2021 |
EX-99.1 2 a52442174ex991.htm EXHIBIT 99.1 Exhibit 99.1 Cross Country Healthcare Completes Asset Acquisition of Workforce Solutions Group, Inc. and Secures New $100 Million Financing BOCA RATON, Fla.-(BUSINESS WIRE)-June 8, 2021-Cross Country Healthcare, Inc., (NASDAQ: CCRN), a leading provider of advisory and workforce solutions, including contingent staffing, permanent placement, and other consul |
|
| June 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| June 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 8, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 17, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 14, 2021 |
Cross Country Healthcare to Attend the Jefferies 2021 Virtual Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the Jefferies 2021 Virtual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-May 14, 2021-Cross Country Healthcare, Inc. (the ?Company?) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Jefferies 2021 Virtual Healthcare Conference taking place June 1-4, 2021. William J. Burns, Executive Vice President & Chief Financial O |
|
| May 14, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 10, 2021 |
Cross Country Healthcare Appoints Phillip Noe as Chief Information Officer Exhibit 99.1 Cross Country Healthcare Appoints Phillip Noe as Chief Information Officer BOCA RATON, Fla.-(BUSINESS WIRE)-May 10, 2021-Cross Country Healthcare, Inc., (NASDAQ: CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Informat |
|
| May 10, 2021 |
Employment Agreement by and between Cross Country Healthcare, Inc. and Phillip Noe Exhibit 10.2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made by and between Cross Country Healthcare, Inc., a Delaware corporation (the ?Company?), and Phillip Noe the employee (the ?Employee?). R E C I T A L S WHEREAS, Company and its affiliates, are engaged on a nationwide and international basis in the traveling healthcare business and local healthcare business of recruiting and placing |
|
| May 10, 2021 |
Offer Letter by and between Cross Country Healthcare, Inc. and Phillip Noe Exhibit 10.1 April 5, 2021 Phillip Noe Dear Phillip, We are pleased to confirm our offer of employment as Chief Information Officer (CIO) (the ?Company?). You will report to Kevin C. Clark, Co-founder, and CEO of the Company. Your start date will be May 10, 2021. You will be compensated for all services rendered by you under this Agreement at the rate of $385,000.00 per annum, payable in a manner |
|
| May 10, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 10, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ??????? FORM 10-Q ??????? ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to ??????? CROSS COUNTRY HEALTHCARE, INC. |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 5, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 5, 2021 |
Cross Country Healthcare Announces First Quarter 2021 Financial Results Exhibit 99.1 Cross Country Healthcare Announces First Quarter 2021 Financial Results BOCA RATON, Fla.-(BUSINESS WIRE)-May 5, 2021-Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2021. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2021 vs Q1 2021 vs Dollars are in thousands, except per share amounts Q1 2021 |
|
| April 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 20, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 20, 2021 |
Cross Country Healthcare to Attend the 2021 BofA Virtual Healthcare Conference Exhibit 99.1 Cross Country Healthcare to Attend the 2021 BofA Virtual Healthcare Conference BOCA RATON, Fla.-(BUSINESS WIRE)-April 20, 2021-Cross Country Healthcare, Inc. (Nasdaq: CCRN) announced today that it is scheduled to participate in the 2021 BofA Virtual Healthcare Conference taking place May 11-13, 2021. Kevin C. Clark, Co-Founder & Chief Executive Officer, and William J. Burns, Executive |
|
| April 14, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 14, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 14, 2021 |
Exhibit 99.1 Cross Country Healthcare Announces First Quarter 2021 Earnings Release Date and Conference Call Information BOCA RATON, Fla.-(BUSINESS WIRE)-April 14, 2021-Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2021 financial results on Wednesday, May 5, 2021 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the ?Com |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 31, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| March 31, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 31, 2021 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| March 31, 2021 |
Cross Country Healthcare Sets the Record Straight on VDA OC Indictment Report: Exhibit 99.1 Cross Country Healthcare Sets the Record Straight on VDA OC Indictment Report: DOJ indictment does not involve Cross Country Healthcare BOCA RATON, Fla.-(BUSINESS WIRE)-March 31, 2021-Cross Country Healthcare, Inc. (NASDAQ: CCRN), today is refuting media reports which erroneously state that a subsidiary and an executive of Cross Country Healthcare were charged in an ongoing US Departm |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 10, 2021 |
Exhibit 10.1 [Execution] AMENDMENT NO. 2 TO ABL CREDIT AGREEMENT AND AMENDMENT NO. 1 TO GUARANTY AND SECURITY AGREEMENT AMENDMENT NO. 2 TO ABL CREDIT AGREEMENT AND AMENDMENT NO. 1 TO GUARANTY AND SECURITY AGREEMENT, dated as of March 8, 2021 (this ?Amendment No. 2?), is by and among Wells Fargo Bank, National Association, a national banking association, as administrative agent for each member of t |
